| Ticker | $ Bought |
|---|---|
| iqvia hldgs inc | 17,256,100 |
| genedx holdings corp | 16,154,200 |
| ascendis pharma a/s | 7,267,840 |
| certara inc | 5,850,000 |
| waystar hldg corp | 5,721,800 |
| incyte corp | 5,107,500 |
| amylyx pharmaceuticals inc | 4,166,500 |
| quanterix corp | 3,431,350 |
| Ticker | % Inc. |
|---|---|
| merus n v | 477 |
| upstream bio inc | 206 |
| mbx biosciences inc | 165 |
| arcellx inc | 158 |
| outset med inc | 137 |
| uniqure nv | 117 |
| quidelortho corp | 110 |
| danaher corporation | 74.06 |
| Ticker | % Reduced |
|---|---|
| urogen pharma ltd | -55.06 |
| day one biopharmaceuticals i | -52.07 |
| precigen inc | -51.66 |
| ultragenyx pharmaceutical in | -51.36 |
| arcus biosciences inc | -50.67 |
| gilead sciences inc | -39.86 |
| kiniksa pharmaceuticals intl | -35.91 |
| cvrx inc | -35.82 |
| Ticker | $ Sold |
|---|---|
| icad inc | -1,610,240 |
| maravai lifesciences hldgs i | -1,458,600 |
| silence therapeutics plc | -1,132,920 |
| vyne therapeutics inc | -344,405 |
| keros therapeutics inc | -2,218,900 |
| ironwood pharmaceuticals inc | -301,476 |
| oric pharmaceuticals inc | -1,132,770 |
| relay therapeutics inc | -492,696 |
Parkman Healthcare Partners LLC has about 86.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 86.9 |
| Others | 10.7 |
| 1.9 |
Parkman Healthcare Partners LLC has about 47.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 44.3 |
| SMALL-CAP | 24.5 |
| MID-CAP | 12.8 |
| UNALLOCATED | 10.7 |
| MICRO-CAP | 4.3 |
| MEGA-CAP | 3 |
About 67.7% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 36.2 |
| Others | 32.3 |
| RUSSELL 2000 | 31.5 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Parkman Healthcare Partners LLC has 87 stocks in it's portfolio. About 32.2% of the portfolio is in top 10 stocks. CVRX proved to be the most loss making stock for the portfolio. THC was the most profitable stock for Parkman Healthcare Partners LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 1.32 | 174,276 | 11,476,100 | added | 158 | ||
| ALNY | alnylam pharmaceuticals inc | 3.46 | 92,338 | 30,110,500 | added | 33.94 | ||
| AMLX | amylyx pharmaceuticals inc | 0.48 | 650,000 | 4,166,500 | new | |||
| ANIP | ani pharmaceuticals inc | 0.96 | 128,478 | 8,383,190 | added | 22.36 | ||
| ANNX | annexon inc | 0.11 | 404,194 | 970,066 | added | 15.01 | ||
| AORT | artivion inc | 0.69 | 192,705 | 5,993,130 | added | 72.59 | ||
| ARDX | ardelyx inc | 0.14 | 301,086 | 1,180,260 | added | 43.66 | ||
| ATEC | alphatec hldgs inc | 0.83 | 648,871 | 7,202,470 | added | 45.45 | ||
| AXGN | axogen inc | 0.84 | 674,551 | 7,318,880 | added | 25.65 | ||
| BCRX | biocryst pharmaceuticals inc | 1.04 | 1,007,990 | 9,031,610 | added | 0.74 | ||
| BDX | becton dickinson & co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 1.42 | 225,150 | 12,376,500 | reduced | -18.79 | ||
| BSX | boston scientific corp | 3.50 | 283,166 | 30,414,900 | added | 25.3 | ||
| CERT | certara inc | 0.67 | 500,000 | 5,850,000 | new | |||
| COO | cooper cos inc | 3.15 | 385,479 | 27,430,700 | added | 23.29 | ||
| CRNX | crinetics pharmaceuticals in | 0.24 | 73,412 | 2,111,330 | added | 14.81 | ||
| CSTL | castle biosciences inc | 0.83 | 352,262 | 7,193,190 | added | 0.49 | ||
| CVRX | cvrx inc | 0.53 | 789,099 | 4,639,900 | reduced | -35.82 | ||
| CVS | cvs health corp | 4.11 | 517,807 | 35,718,300 | added | 4.24 | ||
| DAWN | day one biopharmaceuticals i | 0.37 | 500,000 | 3,250,000 | reduced | -52.07 | ||